Stenram U - Search Results

1

Nucleic acid labeling with [3H]orotic acid and nucleotide profile in rats in protein deprivation, enteral and parenteral essential amino acid administration, and 5-fluorouracil treatment.

Jakobsson B, el Hag IA, Andersson M, Christensson PI, Stenram U. Jakobsson B, et al. Among authors: stenram u. JPEN J Parenter Enteral Nutr. 1990 Sep-Oct;14(5):490-6. doi: 10.1177/0148607190014005490. JPEN J Parenter Enteral Nutr. 1990. PMID: 2122022

2

Incorporation of 5-fluorouracil into RNA of normal tissues and an adenocarcinoma in protein-deprived rats.

el Hag IA, Jakobsson B, Erichsen C, Christensson PI, Jönsson PE, Stenram U. el Hag IA, et al. Among authors: stenram u. In Vivo. 1987 Jul-Aug;1(4):215-20. In Vivo. 1987. PMID: 2485132

3

Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.

el Hag IA, Jakobsson B, Christensson PI, Erichsen C, Jönsson PE, Stenram U. el Hag IA, et al. Among authors: stenram u. In Vivo. 1987 Sep-Oct;1(5):309-12. In Vivo. 1987. PMID: 2485133

4

Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.

Jakobsson B, el Hag IA, Erichsen C, Christensson PI, Jönsson PE, Stenram U. Jakobsson B, et al. Among authors: stenram u. Anticancer Res. 1989 Mar-Apr;9(2):285-90. Anticancer Res. 1989. PMID: 2751255

5

Incorporation of 5-fluorouracil into rat liver tumor and normal tissues and the liver nucleotide profile after administration by the hepatic artery during portal venous branch ligation.

Jakobsson B, Roos G, el Hag IA, Jönsson PE, Stenram U. Jakobsson B, et al. Among authors: stenram u. Res Exp Med (Berl). 1992;192(1):13-21. doi: 10.1007/BF02576253. Res Exp Med (Berl). 1992. PMID: 1570410

6

The incorporation of 5-fluorouracil into rat liver tumor and normal tissues after administration by the hepatic artery during temporary portal vein clamping.

el Hag IA, Jakobsson B, Jönsson PE, Stenram U. el Hag IA, et al. Among authors: stenram u. Res Exp Med (Berl). 1990;190(3):183-92. doi: 10.1007/pl00020021. Res Exp Med (Berl). 1990. PMID: 1695018

7

Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin and RSU-1069.

Roos G, Christensson PI, el Hag IA, Jakobsson B, Teder H, Stenram U. Roos G, et al. Among authors: stenram u. Anticancer Res. 1993 May-Jun;13(3):635-41. Anticancer Res. 1993. PMID: 8317891

8

The antitumor effect of a novel nitrosourea, tauromustine, at intravenous administration in rat. Cure of hepatomas.

Roos G, el Hag IA, Christensson PI, Stenram U. Roos G, et al. Among authors: stenram u. Anticancer Res. 1991 Sep-Oct;11(5):1763-6. Anticancer Res. 1991. PMID: 1837442

9

Improved antitumor effect of the nitrosourea drugs tauromustine (TCNU) and carmustine (BCNU) on a rat liver adenocarcinoma after hepatic arterial administration with degradable starch microspheres.

Roos G, el Hag IA, Teder H, Stenram U. Roos G, et al. Among authors: stenram u. Anticancer Res. 1991 Jan-Feb;11(1):13-6. Anticancer Res. 1991. PMID: 2018346

10

Hepatic vascular occlusion combined with adriamycin given by the hepatic artery in rats with adenocarcinoma in the liver.

Jakobsson B, el Hag IA, Roos G, Stenram U. Jakobsson B, et al. Among authors: stenram u. Anticancer Res. 1991 Mar-Apr;11(2):733-6. Anticancer Res. 1991. PMID: 2064327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters